
|Articles|April 1, 2003
- Psychiatric Times Vol 20 No 4
- Volume 20
- Issue 4
First Night On-Call, Coronary Care Unit
Poetry of the Times
Advertisement
I'm driving a knife-edge
mountain ridge at midnight,
no lines, no guard rails,
a semi screaming down my lane
ready to crush me with its cargo
of science I still need to learn.
A rusted out Chevy on my tail
scrapes an exhaust pipe and sends
sparks into darkness, their brief light
fading fast as facts I've memorized.
I don't know who will die tonight,
me or them, but I grip the wheel tight,
knuckles lit white by high-beams,
my own heart pounding, heading uphill,
engine moaning, pedal to the metal.
Articles in this issue
over 23 years ago
Global and Social Considerationsover 23 years ago
Security Alerts Trouble American Psycheover 23 years ago
Psychiatry's Hottest Niche Marketsover 23 years ago
The Last Frontier: Going Beyond the Limitsover 23 years ago
Secondary Traumatization in Mental Health Care Providersover 23 years ago
Changes in the Concept of PTSD and Traumaover 23 years ago
The DSM: Not Perfect, but Better Than the Alternativeover 23 years ago
Dump the DSM>!Advertisement
Related to this article

Reach Out and Read serves 4.8 million children, but 23% of parents at 3 centers reported clinician modeling, tied to the greatest home literacy gains.

New data shows cannabis dominates teens’ substance-related ER visits, often with alcohol or stimulants, urging better screening and intervention for psychosis, vomiting.

Compass Pathways has completed its submission of an NDA to the FDA for COMP360 psilocybin for treatment-resistant depression.

Lisa Harding, MD, says ECT, ketamine, TMS, and VNS can work, but evidence on what comes after acute response remains thin.

Why D2 blockade alone falls short in schizophrenia, and what neurotransmitter, genetic and neuroimaging research means for treatment-resistant patients.

Discover expanded psychiatry coverage with new podcasts, interactive digital issues, and event reporting—we are your always-on media hub delivering fresh insights year-round.
Advertisement
Advertisement
Trending on Psychiatric Times
1
NDA Submission Complete: COMP360 Psilocybin for Treatment-Resistant Depression
2
Death, Taxes, and Envy: Treating Creative Patients
3
Shared Decision-Making in MDD Treatment Across the Lifespan
4
Schizophrenia: A Telltale of the Brain’s Complexity
5


